Bionano Genomics, Inc. - Common Stock (BNGO)
3.0693
-0.2907 (-8.65%)
NASDAQ · Last Trade: Apr 6th, 8:41 AM EDT
Detailed Quote
Previous Close | 3.360 |
---|---|
Open | 3.240 |
Bid | 2.900 |
Ask | 3.060 |
Day's Range | 3.050 - 3.240 |
52 Week Range | 2.680 - 72.60 |
Volume | 90,961 |
Market Cap | 856.76M |
PE Ratio (TTM) | -0.0348 |
EPS (TTM) | -88.2 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 85,097 |
Chart
About Bionano Genomics, Inc. - Common Stock (BNGO)
Bionano Genomics Inc is a biotechnology company that focuses on advancing the field of genomics through its innovative optical genome mapping technology. This cutting-edge platform enables researchers and clinicians to visualize and analyze the structure and variations of genomes in real-time, enhancing the understanding of genetic diseases and informing treatment strategies. The company's solutions are employed in a variety of applications, including basic research, clinical diagnostics, and drug development, aiming to revolutionize the way genomic information is utilized in healthcare and scientific exploration. Read More
News & Press Releases
BNGO earnings call for the period ending December 31, 2024.
Via The Motley Fool · March 31, 2025
Via Benzinga · March 31, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · January 27, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · January 27, 2025

Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · January 27, 2025

Via Benzinga · January 3, 2025

BNGO earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 13, 2024

Via Benzinga · October 9, 2024

Via Benzinga · September 30, 2024

BNGO earnings call for the period ending June 30, 2024.
Via The Motley Fool · August 8, 2024

BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024

Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.
Via InvestorPlace · July 16, 2024

Steer clear of these three companies facing significant challenges. Discover why these are risky healthcare stocks to sell.
Via InvestorPlace · May 28, 2024

Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.
Via InvestorPlace · May 10, 2024

BNGO earnings call for the period ending March 31, 2024.
Via The Motley Fool · May 8, 2024

BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive.
Via InvestorPlace · April 25, 2024

BNGO earnings call for the period ending December 31, 2023.
Via The Motley Fool · March 6, 2024

BNGO stock results show that Bionano Genomics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 5, 2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via Benzinga · March 5, 2024